Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Victoria

$40,000.00

Nicotinic regulation of neurotransmission in the CNS

EF 2012-13

Résumé
The transmission of information between neurons in the brain is governed by the release of chemicals called ""neurotranmitters"" which bind to ion channels located on the surface of neurons. The binding of neurotransmitters to ion channels transduces changes in electrical activity of the neuron via the flux of ions across the membrane. The present study focuses on a class of ligand-gated ion channels called nicotinic acetylcholine receptors. alpha4beta2 is the most prevalent nicotinic receptor subtype in the CNS. Our long term goal is to examine the basic function of nicotinic receptors in modulating neurotransmission in the CNS. To address this issue we have produced three lines of knock-in mice, whereby a nicotinic receptor subunit (alpha4) was mutated to contain a fluorescent tag allowing us to localize the receptor in the CNS with exquisite detail. One of the mouse lines also contains a gain-of-function mutation rendering nicotinic receptors with several fold larger nicotinic currents and 50 fold greater affinity to nicotine. This mouse line will allow us to specifically target the receptor with very low concentrations of nicotinic agonist to unambiguously ascertain the receptor's function in physiology and behavioral experiments. We plan to achieve our overall goal firstly by imaging the localization and quantifying nicotinic receptors in specific neurons in various brain regions by exploiting the alpha4 fluorescent mouse lines. To our knowledge, these mice are the first knock-ins to express fluorescently tagged ion channels. After mapping the location and quantifying the receptor we can then precisely target specific neurons for electrophysiological recordings and design intelligently the experiments to ascertain the function of the receptor in influencing neuronal excitability. By knowing the precise quantity and subcellular localization and function of nicotinic receptors in specific neurons and circuits in the brain, we can then predict and test the role of the nicotinic receptor in modulating certain behaviors, such as reward, cognition and pain. We are also interested in understanding the function of other nicotinic receptor subtypes and we will produce fluorescently tagged alpha7 nicotinic receptors as a first step in this endeavor.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
355822-2008
Name nom
Nashmi, Raad
Department département
Biology
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2008
Award amount
40000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5112
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Electrophysiology
Research subject fr
Électrophysiologie
Partie
5
Nb partie
5
Application title
Nicotinic regulation of neurotransmission in the CNS
Keyword
NSERC
Application summary
The transmission of information between neurons in the brain is governed by the release of chemicals called ""neurotranmitters"" which bind to ion channels located on the surface of neurons. The binding of neurotransmitters to ion channels transduces changes in electrical activity of the neuron via the flux of ions across the membrane. The present study focuses on a class of ligand-gated ion channels called nicotinic acetylcholine receptors. alpha4beta2 is the most prevalent nicotinic receptor subtype in the CNS. Our long term goal is to examine the basic function of nicotinic receptors in modulating neurotransmission in the CNS. To address this issue we have produced three lines of knock-in mice, whereby a nicotinic receptor subunit (alpha4) was mutated to contain a fluorescent tag allowing us to localize the receptor in the CNS with exquisite detail. One of the mouse lines also contains a gain-of-function mutation rendering nicotinic receptors with several fold larger nicotinic currents and 50 fold greater affinity to nicotine. This mouse line will allow us to specifically target the receptor with very low concentrations of nicotinic agonist to unambiguously ascertain the receptor's function in physiology and behavioral experiments. We plan to achieve our overall goal firstly by imaging the localization and quantifying nicotinic receptors in specific neurons in various brain regions by exploiting the alpha4 fluorescent mouse lines. To our knowledge, these mice are the first knock-ins to express fluorescently tagged ion channels. After mapping the location and quantifying the receptor we can then precisely target specific neurons for electrophysiological recordings and design intelligently the experiments to ascertain the function of the receptor in influencing neuronal excitability. By knowing the precise quantity and subcellular localization and function of nicotinic receptors in specific neurons and circuits in the brain, we can then predict and test the role of the nicotinic receptor in modulating certain behaviors, such as reward, cognition and pain. We are also interested in understanding the function of other nicotinic receptor subtypes and we will produce fluorescently tagged alpha7 nicotinic receptors as a first step in this endeavor.